川發龍蟒(002312.SZ):擬4.9億元投建年產5萬噸新能源材料磷酸鐵及40萬噸硫磺制酸項目
格隆匯9月23日丨川發龍蟒(002312.SZ)公佈,公司於2022年9月23日召開第六屆董事會第二十九次會議,全票同意通過了《關於荊州川發龍蟒新材料有限公司投資建設年產5萬噸新能源材料磷酸鐵及40萬噸硫磺制酸項目的議案》。
同意全資子公司荊州川發龍蟒新材料有限公司(簡稱“荊州川發龍蟒”)在湖北省荊州市松滋經濟開發區臨港工業園投資4.9億元建設年產5萬噸新能源材料磷酸鐵及40萬噸硫磺制酸項目;同意荊州川發龍蟒與松滋市政府簽署《投資合同書》;同意授權荊州川發龍蟒管理層按照相關法律、法規及公司管理制度辦理該次項目投資有關具體事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.